HOME  Company Info  Contact
HOME Company Info Contact
0086-838-2518267 (from 9:am to 5:00pm) ; Email: info@onecoup.com
NEWSLETTER
Subscribe
Unsubscribe
Newsletter Center
Home > Knowledge>Clinical
This section provides up-to-date medical knowledge and to some extent knowledge of traditional Chinese medicine, thus enabling more people to be general practitioners fully equipped with the expertise of clinical medicine.
Clinical
What is Glucagon-like peptide-1(2010/9/9 4:34:04)

Glucagon-like peptide-1 (GLP-1) is derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. The biologically active forms of GLP-1 are: GLP-1-(7-37) and GLP-1-(7-36)NH2.

GLP-1 secretion by L cells is dependent on the presence of nutrients in the lumen of the small intestine. The secretagogues (agents that cause or stimulate secretion) of this hormone include major nutrients like carbohydrate, protein and lipid. Once in the circulation, GLP-1 has a half life of less than 2 minutes, due to rapid degradation by the enzyme dipeptidyl peptidase-4. It is a potent antihyperglycemic hormone, inducing glucose-dependent stimulation of insulin secretion while suppressing glucagon secretion. Such glucose-dependent action is particularly attractive because when the plasma glucose concentration is in the normal fasting range, GLP-1 no longer stimulates insulin to cause hypoglycemia. GLP-1 appears to restore the glucose sensitivity of pancreatic β-cells , with the mechanism possibly involving the increased expression of GLUT2 and glucokinase. GLP-1 is also known to inhibit pancreatic β-cell apoptosis and stimulate the proliferation and differentiation of insulin-secreting β-cells. In addition, GLP-1 inhibits gastric secretion and motility. This delays and protracts carbohydrate absorption and contributes to a satiating effects.

     
Special Programs:

If you have any questions, please contact us by info@onecoup.com

Onecoup Lifescience